New digital app for adults with acute myeloid leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a digital application to help patients with acute myeloid leukemia (AML) during their hospital stay. It may assist with tracking symptoms, education, or communication with care teams.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently hospitalized and have been diagnosed with AML (acute myeloid leukemia).
- You are starting treatment with either intensive chemotherapy (like 7+3) or a hypomethylating agent (a type of targeted therapy), possibly combined with other drugs or on a clinical trial.
- This can be your first diagnosis (newly diagnosed) or if your AML has come back or is not responding to previous treatment (relapsed or refractory).
- You must be able to understand and speak English because the digital app is only available in English.
- You do not have acute promyelocytic leukemia (APL), a specific subtype of AML. You also do not have active or unstable psychiatric or cognitive conditions that would interfere with giving consent or following study steps.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is beta-testing a new app designed to reduce healthcare disparities among people admitted to the hospital with suspected acute leukemia. Your feedback could help make the app more helpful for future patients.
This trial is testing a digital lifestyle app designed to help people with myeloproliferative neoplasms (MPNs) manage their health and wellness. By using the app, you may get support in tracking symptoms, lifestyle habits, and connecting with resources that could improve your quality of life.
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
This study tests a digital way for older adults with acute leukemia to report their symptoms and quality of life from home. Instead of only talking to your doctor at appointments, you might use an app or a website to answer questionnaires, which could help your care team notice issues earlier and adjust your care.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
This study tests a digital tool to help doctors keep an eye on patients with chronic myeloid leukemia who have stopped their treatment. It may help ensure you stay well after stopping treatment.
Hear when a new High Risk Acute Myeloid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.